Deal fatigue (announced in December 2023) and Ibiden's derating will nudge shareholders to accept. At the last close and for an end-of-March payment, the gross/annualised spread was 0.7%/3.9%
What is covered in the Full Insight:
Introduction to the Tender Offer
Recap of Key Events
Regulatory Approval Status
Comparison with Peers
Summary and Outlook
Boomeranged on Tue, 18 Feb 2025 01:36
The precondition is satisfied, and the tender offer is from 18 February to 18 March (20 business days). Deal fatigue and the derating of Ibiden will nudge shareholders to accept. This is a done deal. At the last close, for a 26 March payment, the gross/annualised spread was 0.9%/9.4%.